Sorry, you need to enable JavaScript to visit this website.
Skip to main content

All materials and content available on the website are of strictly non-promotional nature and only intended for healthcare professionals (HCPs) practicing in Europe. Kindly note that materials and content are not intended for any specific country and approval conditions for products may vary from country to country. Before prescribing any product, always refer to the approved label in the relevant country and/or the Summary of Product Characteristics.

  • November 08, 2024
  • Glomerular Disease

New treatment options for IgAN, along with real-world data for sparsentan: Comprehensive review by Prof. Jörg Latus

Explore the science
  • October 31, 2024
  • Glomerular Disease

Innovative Ansätze zur IgAN-Therapie: Vortrag von Prof. Huynh Do

Explore the science
  • October 18, 2024
  • Glomerular Disease

Introduction to IgAN

Explore the science
  • October 18, 2024
  • Glomerular Disease

Unmet need in IgAN

Explore the science
  • October 03, 2024
  • Glomerular Disease

3 minutes to deep dive into the pathophysiology of IgAN and why proteinuria matters

Explore the science
  • October 03, 2024
  • Glomerular Disease

Learn in 2 minutes: Proteinuria and Dual Pathway in IgAN

Explore the science
  • March 14, 2024
  • Iron Deficiency

Webinar Update for general practitioners

Explore the science
  • February 06, 2024
  • Iron Deficiency

Webinar Update for general practitioners

Explore the science
  • May 04, 2023
  • CKD-MBD and SHPT

Extended Release Calcifediol (ERC) in Secondary Hyperparathyroidism (SHPT): A new option that challenges the current therapeutic approach. From studies to your clinical practice.

Explore the science